|
KR20190053159A
|
|
Diagnostic Method for Parkinson's disease with dementia and Diagnostic Kit therefor
|
|
KR20190053158A
|
|
Diagnostic Method for Parkinson's disease and Diagnostic Kit therefor
|
|
KR20190038527A
|
|
Method for Detecting Aggregate Form of Aggregate-Forming Polypeptides
|
|
KR20170108203A
|
|
Method for Detecting Aggregate Form of Aggregate-Forming Polypeptides
|
|
KR20160067026A
|
|
Method for Detecting Multimeric Form from Monomeric Form of Multimer-Forming Polypeptides
|
|
KR20150008309A
|
|
Method for Differentially Detecting a Multimeric Form from a Monomeric Form of Multimer-Forming Polypeptides in Blood Samples
|
|
KR20090007962A
|
|
Methods for decreasing false signals in immunoassay to detect a multimeric form from a monomeric form of multimer-forming polypeptides
|
|
EP2010904A1
|
|
Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides through three-dimensional interactions
|
|
CN101427132A
|
|
Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides through three-dimensional interactions
|
|
WO2008029965A1
|
|
Simultaneous reaction assay for differentially detecting multimeric form
|
|
CA2598321A1
|
|
Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides
|
|
CN101124342A
|
|
Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides
|
|
KR20060025296A
|
|
Antibodies against cellular form of prion and uses thereof
|
|
KR20050102304A
|
|
Interaction between transglutaminase and prion protein
|
|
KR20050086253A
|
|
Method for purifying polyclonal antibody specific to misfolding form of protein
|
|
WO2005038045A1
|
|
Method and kit for measuring the activity of factor xiii
|
